Nina Mufti

435 total citations
23 papers, 282 citations indexed

About

Nina Mufti is a scholar working on Hematology, Physiology and Biochemistry. According to data from OpenAlex, Nina Mufti has authored 23 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 13 papers in Physiology and 8 papers in Biochemistry. Recurrent topics in Nina Mufti's work include Erythrocyte Function and Pathophysiology (13 papers), Blood groups and transfusion (11 papers) and Blood transfusion and management (8 papers). Nina Mufti is often cited by papers focused on Erythrocyte Function and Pathophysiology (13 papers), Blood groups and transfusion (11 papers) and Blood transfusion and management (8 papers). Nina Mufti collaborates with scholars based in United States, Germany and United Kingdom. Nina Mufti's co-authors include Anne North, Laurence Corash, Erhard Seifried, Reinhard Henschler, Anna Erickson, L. Lin, Vic Ciaravino, Lynette Sawyer, Richard J. Benjamin and José A. Cancelas and has published in prestigious journals such as Blood, British Journal of Haematology and Transfusion.

In The Last Decade

Nina Mufti

21 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Mufti United States 10 132 100 82 78 54 23 282
Barbara Hannach Canada 11 182 1.4× 124 1.2× 70 0.9× 37 0.5× 46 0.9× 17 331
Yasmin Ayob Malaysia 9 45 0.3× 85 0.8× 74 0.9× 18 0.2× 19 0.4× 25 283
Sonny Michael Assennato United Kingdom 6 43 0.3× 28 0.3× 60 0.7× 17 0.2× 46 0.9× 11 261
Rita A. Reik United States 7 42 0.3× 43 0.4× 57 0.7× 9 0.1× 25 0.5× 16 168
Eiad Kahwash United States 6 31 0.2× 52 0.5× 23 0.3× 21 0.3× 7 0.1× 14 122
Chantale Pambrun Canada 8 9 0.1× 31 0.3× 6 0.1× 11 0.1× 13 0.2× 16 141
Joseph Smolens United States 5 9 0.1× 31 0.3× 14 0.2× 11 0.1× 27 0.5× 9 191
Xianming Zhu United States 6 17 0.1× 11 0.1× 10 0.1× 2 0.0× 11 0.2× 28 116
Jiraporn Kuesap Thailand 11 2 0.0× 28 0.3× 1 0.0× 18 0.2× 158 2.9× 23 288
Salih Yürek Germany 7 5 0.0× 168 1.7× 118 1.5× 86 1.6× 13 277

Countries citing papers authored by Nina Mufti

Since Specialization
Citations

This map shows the geographic impact of Nina Mufti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Mufti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Mufti more than expected).

Fields of papers citing papers by Nina Mufti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Mufti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Mufti. The network helps show where Nina Mufti may publish in the future.

Co-authorship network of co-authors of Nina Mufti

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Mufti. A scholar is included among the top collaborators of Nina Mufti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Mufti. Nina Mufti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benjamin, Richard J., Shengnan Huang, Anna Erickson, et al.. (2025). A novel acridine flow cytometry marker to track post‐transfusion amustaline/glutathione pathogen‐reduced red blood cell survival in sickle cell disease patients. Transfusion. 65(5). 909–920. 1 indexed citations
3.
Panigrahi, Anil K., Ronald G. Pearl, Neel R. Sodha, et al.. (2024). Characterizing the antibody response to amustaline/glutathione pathogen‐reduced red blood cells. Transfusion. 65(2). 344–353. 2 indexed citations
4.
North, Anne, Leon F. Stankowski, Stanley Bentow, et al.. (2024). In vivo genotoxicity assessment of N‐(‐9 acridinyl)‐b‐alanine hydrochloride (S‐300) using a validated Pig‐a mutagenesis assay. Transfusion. 64(6). 1097–1108. 2 indexed citations
5.
6.
Benjamin, Richard J., et al.. (2023). P‐TS‐25 | Developing a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen‐Reduced RBCs. Transfusion. 63(S5). 2 indexed citations
7.
North, Anne, et al.. (2020). Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione. Transfusion. 60(2). 358–366. 3 indexed citations
8.
Geisen, Christof, Anne North, Lisa Becker, et al.. (2020). Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells. Transfusion. 60(10). 2389–2398. 5 indexed citations
9.
Lanteri, Marion C., et al.. (2019). Progress towards an appropriate pathogen reduction technology for whole blood in Africa. ISBT Science Series. 15(1). 151–163. 7 indexed citations
10.
Aydınok, Yeşim, Antonio Piga, Raffaella Origa, et al.. (2019). Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia. British Journal of Haematology. 186(4). 625–636. 18 indexed citations
11.
Brixner, V., AH Kiessling, Katharina Madlener, et al.. (2018). Red blood cells treated with the amustaline (S‐303) pathogen reduction system: a transfusion study in cardiac surgery. Transfusion. 58(4). 905–916. 23 indexed citations
12.
Erickson, Anna, Tovo David, Salvador Rico, et al.. (2017). Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post‐thaw storage at 1 to 6oC. Transfusion. 57(4). 997–1006. 9 indexed citations
13.
Meli, Athinoula, et al.. (2016). Quality of red cells after combination of prion reduction and treatment with the intercept system for pathogen inactivation. Transfusion Medicine. 26(3). 208–214. 9 indexed citations
14.
Winter, Kelly, et al.. (2014). Red blood cell in vitro quality and function is maintained after S‐303 pathogen inactivation treatment. Transfusion. 54(7). 1798–1807. 19 indexed citations
15.
Knutson, Folke, et al.. (2013). Quality Of Inactivated Red Cells Compared To Gamma Irradiated Red Cells. Vox Sanguinis. 105. 151–152. 3 indexed citations
16.
Henschler, Reinhard, Erhard Seifried, & Nina Mufti. (2011). Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates. Transfusion Medicine and Hemotherapy. 38(1). 33–42. 49 indexed citations
17.
Cancelas, José A., Larry J. Dumont, Neeta Rugg, et al.. (2011). Stored red blood cell viability is maintained after treatment with a second‐generation S‐303 pathogen inactivation process. Transfusion. 51(11). 2367–2376. 31 indexed citations
18.
Erickson, Anna, Johannes Leibacher, M. Giesen, et al.. (2011). In vitro evaluation of pathogen inactivated RBC using the S-303 treatment system. 2. 1 indexed citations
19.
North, Anne, Vic Ciaravino, Nina Mufti, & Laurence Corash. (2011). Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S‐303 pathogen inactivation treatment. Transfusion. 51(10). 2208–2218. 23 indexed citations
20.
Mufti, Nina, Anna Erickson, Anne North, et al.. (2009). Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC. Biologicals. 38(1). 14–19. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Hannach Breakdown of academic impact, for papers by Yasmin Ayob Breakdown of academic impact, for papers by Sonny Michael Assennato Breakdown of academic impact, for papers by Rita A. Reik Breakdown of academic impact, for papers by Eiad Kahwash Breakdown of academic impact, for papers by Chantale Pambrun Breakdown of academic impact, for papers by Joseph Smolens Breakdown of academic impact, for papers by Xianming Zhu Breakdown of academic impact, for papers by Jiraporn Kuesap Breakdown of academic impact, for papers by Salih Yürek
Rankless by CCL
2026